Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest BRAIDWELL LP Stock Portfolio

$3.19Billion– No. of Holdings #58

BRAIDWELL LP Performance:
2024 Q2: -6.12%YTD: -1.52%2023: -6.08%

Performance for 2024 Q2 is -6.12%, and YTD is -1.52%, and 2023 is -6.08%.

About BRAIDWELL LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, BRAIDWELL LP reported an equity portfolio of $3.2 Billions as of 30 Jun, 2024.

The top stock holdings of BRAIDWELL LP are NBIX, , XENE. The fund has invested 3.3% of it's portfolio in NEUROCRINE BIOSCIENCES INC and 3.3% of portfolio in CG ONCOLOGY INC.

The fund managers got completely rid off AVADEL PHARMACEUTICALS PLC (AVDL), KINIKSA PHARMACEUTICALS LTD (KNSA) and TOURMALINE BIO INC stocks. They significantly reduced their stock positions in CULLINAN THERAPEUTICS INC (CGEM), OUTSET MED INC (OM) and TRANSMEDICS GROUP INC (TMDX). BRAIDWELL LP opened new stock positions in EXACT SCIENCES CORP (EXAS), AVADEL PHARMACEUTICALS PLC and IMMUNOCORE HLDGS PLC (IMCR). The fund showed a lot of confidence in some stocks as they added substantially to SPYRE THERAPEUTICS INC (AGLE), INSPIRE MED SYS INC (INSP) and CG ONCOLOGY INC.
BRAIDWELL LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024

BRAIDWELL LP Annual Return Estimates Vs S&P 500

Our best estimate is that BRAIDWELL LP made a return of -6.12% in the last quarter. In trailing 12 months, it's portfolio return was -7.09%.

New Buys

Ticker$ Bought
dexcom inc81,211,400
exact sciences corp48,235,900
avadel pharmaceuticals plc40,754,900
kiniksa pharmaceuticals intl38,428,500
immunocore hldgs plc27,019,400
akero therapeutics inc25,440,000
apellis pharmaceuticals inc23,468,600
alphatec hldgs inc22,936,700

New stocks bought by BRAIDWELL LP

Additions to existing portfolio by BRAIDWELL LP

Reductions

Ticker% Reduced
cullinan therapeutics inc-85.8
outset med inc-71.07
transmedics group inc-69.09
4d molecular therapeutics in-64.9
haemonetics corp mass-46.51
krystal biotech inc-39.48
vaxcyte inc-33.35
penumbra inc-28.15

BRAIDWELL LP reduced stake in above stock

Sold off

Ticker$ Sold
exact sciences corp-133,114,000
karyopharm therapeutics inc-35,793,200
insmed inc-69,429,100
ironwood pharmaceuticals inc-19,937,500
dbv technologies s a-5,927,170
biocryst pharmaceuticals inc-17,168,300
avadel pharmaceuticals plc-45,071,800
kiniksa pharmaceuticals ltd-27,478,300

BRAIDWELL LP got rid off the above stocks

Sector Distribution

BRAIDWELL LP has about 76.2% of it's holdings in Healthcare sector.

Sector%
Healthcare76.2
Others23.3

Market Cap. Distribution

BRAIDWELL LP has about 16.2% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP33.2
SMALL-CAP24.7
UNALLOCATED24.7
LARGE-CAP14.2
MEGA-CAP2
MICRO-CAP1.3

Stocks belong to which Index?

About 47.1% of the stocks held by BRAIDWELL LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others52.9
RUSSELL 200039.4
S&P 5007.7
Top 5 Winners (%)%
TMDX
transmedics group inc
87.4 %
OM
outset med inc
58.2 %
HROW
harrow inc
45.9 %
LBPH
longboard pharmaceuticals in
38.9 %
GH
guardant health inc
37.5 %
Top 5 Winners ($)$
TMDX
transmedics group inc
39.7 M
GH
guardant health inc
22.1 M
GKOS
glaukos corp
11.3 M
CGEM
cullinan therapeutics inc
6.2 M
PCVX
vaxcyte inc
5.4 M
Top 5 Losers (%)%
ELEV
elevation oncology inc
-46.8 %
NVRO
nevro corp
-41.2 %
FNA
paragon 28 inc
-40.5 %
IOVA
iovance biotherapeutics inc
-35.9 %
LUNG
pulmonx corp
-31.6 %
Top 5 Losers ($)$
VKTX
viking therapeutics inc
-25.5 M
FNA
paragon 28 inc
-19.3 M
ALGN
align technology inc
-17.8 M
INSP
inspire med sys inc
-17.6 M
KROS
keros therapeutics inc
-17.0 M

BRAIDWELL LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BRAIDWELL LP

BRAIDWELL LP has 58 stocks in it's portfolio. About 25.8% of the portfolio is in top 10 stocks. VKTX proved to be the most loss making stock for the portfolio. TMDX was the most profitable stock for BRAIDWELL LP last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions